These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27455907)

  • 1. Characteristics of infants exposed to maternal tuberculosis and chemoprophylaxis using 3 months of isoniazid and rifampicin.
    Mathivha KT; Velaphi S
    Paediatr Int Child Health; 2017 May; 37(2):129-134. PubMed ID: 27455907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infants.
    McIlleron H; Denti P; Cohn S; Mashabela F; Hoffmann JD; Shembe S; Msandiwa R; Wiesner L; Velaphi S; Lala SG; Chaisson RE; Martinson N; Dooley KE;
    J Antimicrob Chemother; 2017 Jul; 72(7):2028-2034. PubMed ID: 28419277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues.
    Skevaki CL; Kafetzis DA
    Paediatr Drugs; 2005; 7(4):219-34. PubMed ID: 16117559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.
    Sneag DB; Schaaf HS; Cotton MF; Zar HJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1142-6. PubMed ID: 18043453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children.
    Bright-Thomas R; Nandwani S; Smith J; Morris JA; Ormerod LP
    Arch Dis Child; 2010 Aug; 95(8):600-2. PubMed ID: 20530147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemoprophylaxis of tuberculosis].
    Anthoine D; Derelle J
    Rev Prat; 1990 Mar; 40(8):731-2. PubMed ID: 2320898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
    Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
    Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.
    Gupta A; Nayak U; Ram M; Bhosale R; Patil S; Basavraj A; Kakrani A; Philip S; Desai D; Sastry J; Bollinger RC;
    Clin Infect Dis; 2007 Jul; 45(2):241-9. PubMed ID: 17578786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial.
    Gupta A; Singh P; Aaron L; Montepiedra G; Chipato T; Stranix-Chibanda L; Chanaiwa V; Vhembo T; Mutambanengwe M; Masheto G; Raesi M; Bradford S; Golner A; Costello D; Kulkarni V; Shayo A; Kabugho E; Jean-Phillippe P; Chakhtoura N; Sterling TR; Theron G; Weinberg A;
    Lancet Child Adolesc Health; 2023 Oct; 7(10):708-717. PubMed ID: 37634517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to anti-tuberculosis chemoprophylaxis and treatment in children.
    van Zyl S; Marais BJ; Hesseling AC; Gie RP; Beyers N; Schaaf HS
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):13-8. PubMed ID: 16466031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial exposure to active pulmonary tuberculosis in a neonatal intensive care unit.
    Ahn JG; Kim DS; Kim KH
    Am J Infect Control; 2015 Dec; 43(12):1292-5. PubMed ID: 26307044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana.
    Sibanda T; Tedla Z; Nyirenda S; Agizew T; Marape M; Miranda AG; Reuter H; Johnson JL; Samandari T
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):178-85. PubMed ID: 23317952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
    Swaminathan S; Narendran G; Venkatesan P; Iliayas S; Santhanakrishnan R; Menon PA; Padmapriyadarsini C; Ramachandran R; Chinnaiyan P; Suhadev M; Sakthivel R; Narayanan PR
    Am J Respir Crit Care Med; 2010 Apr; 181(7):743-51. PubMed ID: 19965813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spanish Society for Pediatric Infectious Diseases guidelines on tuberculosis in pregnant women and neonates (ii): Prophylaxis and treatment].
    Baquero-Artigao F; Mellado Peña MJ; del Rosal Rabes T; Noguera Julián A; Goncé Mellgren A; de la Calle Fernández-Miranda M; Navarro Gómez ML;
    An Pediatr (Barc); 2015 Oct; 83(4):286.e1-7. PubMed ID: 25754314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
    Halsey NA; Coberly JS; Desormeaux J; Losikoff P; Atkinson J; Moulton LH; Contave M; Johnson M; Davis H; Geiter L; Johnson E; Huebner R; Boulos R; Chaisson RE
    Lancet; 1998 Mar; 351(9105):786-92. PubMed ID: 9519950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
    Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
    Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.